Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104725335B details high-purity Escitalopram Hydrobromide synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN113151375B reveals enzymatic synthesis improving yield and safety. Reliable supplier for cost reduction in sweetener manufacturing and supply chain stability.
Patent CN102177169A details a catalytic route for mono-vinyl phosphinic acids. This technology enables cost reduction in flame retardant manufacturing with high purity.
Patent CN113912577A details a novel dual-catalytic asymmetric allylation for high-purity Rocaglaol intermediates, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1177958A details a lipase-catalyzed resolution of pyrazole carbinols. Discover cost-effective, high-purity manufacturing solutions for analgesic intermediates.
Patent CN112608274A reveals a novel Pd-catalyzed route for chiral amines. Discover cost reduction in chiral amine manufacturing and scalable supply chain solutions.
Patent CN111848374A details a streamlined 10-step asymmetric synthesis of high-purity gossypol enantiomers, offering significant cost reduction and scalability for API manufacturing.
Patent CN102977076A reveals a high-purity R-lansoprazole synthesis using chiral titanium catalysis. Discover cost-effective manufacturing insights for pharmaceutical supply chains.
Patent CN105777544B enables high-purity synthesis. Reduces racemization risks and ensures supply chain stability for global pharmaceutical manufacturers.
Patent CN111217844A details a Cp2ZrCl2-catalyzed method for 1,1-diboronation. Offers high atom economy and scalability for pharma intermediates.
Patent CN111217844A details a zirconium-catalyzed 1,1-diboronation method. This breakthrough offers cost reduction in fine chemical manufacturing and high-purity organoboron intermediates.
Patent CN104860911B reveals a metal-free synthesis for chiral 3,4-dihydrocoumarin derivatives. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Novel Lewis acid catalyzed synthesis offers high yield and safety for pharmaceutical intermediate manufacturing supply chains.
Novel carbene catalysis enables efficient production of chiral dihydrocoumarin derivatives with dual chiral centers, offering significant supply chain stability.
Patent CN105837544B details a rare earth catalyzed synthesis offering high purity and environmental safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105837544B details a green synthesis route for coumarin derivatives using rare earth catalysts, offering supply chain stability and cost efficiency.
Novel acid-catalyzed acylcyanation of electron-rich alkynes. High selectivity, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110698313B details a novel Ru-catalyzed route for (Z)-4-trifluoromethyl-5-sulfanyl-4-pentenone derivatives, offering mild conditions and high stereoselectivity for pharma intermediates.
Discover the novel synthesis of potential antiviral intermediate BL via patent CN115894498A. Offers high diastereoselectivity and scalable manufacturing for global supply chains.
Advanced patent CN111153818A details a robust method for Oseltamivir intermediates, eliminating solidification issues and ensuring high-purity supply chain continuity.